Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (53 quarters reported)
$440M in Q2 2013 → $1.91B now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| MB Monster Beverage Corp New | 40.7% | Unchanged | 8,107,796 | $779M |
| Staar Surgical Co | 24.2% | Unchanged | 16,123,842 | $463M |
| Axon Enterprise Inc | 20.3% | Unchanged | 693,504 | $389M |
| IT Ishares Tr | 7.5% | Unchanged | 474,920 | $143M |
| IM Insight Molecular Dia Inc | 3.9% | Added 6.3% | 12,684,884 | $74.8M |
| LC Lineage Cell Therapeutics In | 3.4% | Unchanged | 49,560,992 | $64.9M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IM Insight Molecular Dia Inc | Added | +753,045 | +$4.44M | 3.9% |
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Staar Surgical Co | Added | +1,104,351 | +$20.7M | 21.3% |
| UA United Airls Hldgs Inc | Exited | −150,000 | −$16.8M | — |
| AA American Airls Group Inc | Exited | −820,000 | −$12.6M | — |
| SA Southwest Airls Co | Exited | −183,000 | −$7.56M | — |
| Gildan Activewear Inc | Exited | −112,750 | −$7.04M | — |
| MB Monster Beverage Corp New | Trimmed | −91,200 | −$6.61M | 41.4% |
| DA Delta Air Lines Inc Del | Exited | −52,500 | −$3.64M | — |
| IM Insight Molecular Dia Inc | Added | +521,739 | +$1.71M | 2.8% |
| Serina Therapeutics Inc | Exited | −54,484 | −$104K | — |
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Staar Surgical Co | Added | +1,500,000 | +$34.6M | 20.4% |
| Gildan Activewear Inc | New | +112,750 | +$7.04M | 0.4% |
| MB Monster Beverage Corp New | Trimmed | −51,432 | −$3.94M | 36.9% |
| Hanesbrands Inc | Exited | −1,127,500 | −$1.83M | — |
| Serina Therapeutics Inc | Trimmed | −28,711 | −$54.9K | — |
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Olo Inc | Exited | −3,782,821 | −$33.7M | — |
| Axon Enterprise Inc | Trimmed | −760 | −$545K | 30.0% |
| MB Monster Beverage Corp New | Trimmed | −5,000 | −$337K | 33.4% |
| Serina Therapeutics Inc | Trimmed | −2,024 | −$10.8K | — |
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Staar Surgical Co | Added | +1,064,227 | +$17.9M | 14.5% |
| Olo Inc | Added | +2,000,487 | +$17.8M | 2.1% |
| UA United Airls Hldgs Inc | New | +150,000 | +$11.9M | 0.8% |
| AA American Airls Group Inc | New | +820,000 | +$9.2M | 0.6% |
| SA Southwest Airls Co | New | +183,000 | +$5.94M | 0.4% |
| Hanesbrands Inc | New | +1,127,500 | +$5.16M | 0.3% |
| DA Delta Air Lines Inc Del | New | +52,500 | +$2.58M | 0.2% |
| MB Monster Beverage Corp New | Trimmed | −40,262 | −$2.52M | 32.9% |
| Axon Enterprise Inc | Trimmed | −1,811 | −$1.5M | 36.6% |
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Staar Surgical Co | Added | +1,606,633 | +$28.3M | 17.8% |
| O Oncocyte Corp | Added | +5,165,695 | +$15.8M | 2.8% |
| Axon Enterprise Inc | Trimmed | −26,346 | −$13.9M | 29.7% |
| Olo Inc | New | +1,782,334 | +$10.8M | 0.9% |
| IT Ishares Tr | Trimmed | −45,000 | −$8.98M | 7.7% |
| LC Lineage Cell Therapeutics In | Added | +7,894,737 | +$3.57M | 1.8% |
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Axon Enterprise Inc | Trimmed | −37,641 | −$22.4M | 33.5% |
| O Oncocyte Corp | Added | +1,315,339 | +$3.13M | 1.2% |
| Staar Surgical Co | Added | +80,200 | +$1.95M | 20.6% |
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Trimmed | −46,080 | −$10.2M | 8.8% |
Loading...